LEIDOS BIOMEDICAL RESEARCH INC
Federal contract award, Leidos, $16,869,382
Key CONT_AWD_75N91022F00010_7529_75N91019D00024_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 94 days before this system saw it. One version on record.
Cite this row
8f2d07dad6d087952aac6d00d398a503a234981acb6ac24a9e1c7e108a48c5deThe source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.
Versions
| Version | Amount | Change | Occurred | Published | Retrieved | How it arrived | Content hash |
|---|---|---|---|---|---|---|---|
| 1 current | $16,869,382 | first version | July 26, 2022 | June 3, 2026 | 2026-09-05T00:54:54Z | historical sweep | 8f2d07dad6d0 |
Archived copy
None on file. An archived copy is optional corroboration and never a condition of this filing’s provenance, which is the stored response and its hash above; see the methodology page.
What the amount is made of
7 recorded actions, so the amount is the award's current total across all of them. 3 of them obligated money. Measured 2026-10-12, when USAspending reported a total obligation of $16,869,382.
| Action date | Modification | Type | Obligated | Description as recorded |
|---|---|---|---|---|
| June 3, 2026 | P00006 | OTHER ADMINISTRATIVE ACTION | no money | IND-DIRECTED DEVELOPMENT OF ANTIVIRAL THERAPIES TO COMBAT DISEASES OF PANDEMIC POTENTIAL |
| December 1, 2025 | P00005 | OTHER ADMINISTRATIVE ACTION | −$1,843,960 | IND-DIRECTED DEVELOPMENT OF ANTIVIRAL THERAPIES TO COMBAT DISEASES OF PANDEMIC POTENTIAL |
| May 23, 2024 | P00004 | OTHER ADMINISTRATIVE ACTION | no money | IND-DIRECTED DEVELOPMENT OF ANTIVIRAL THERAPIES TO COMBAT DISEASES OF PANDEMIC POTENTIAL |
| April 24, 2023 | P00003 | OTHER ADMINISTRATIVE ACTION | no money | IND-DIRECTED DEVELOPMENT OF ANTIVIRAL THERAPIES TO COMBAT DISEASES OF PANDEMIC POTENTIAL |
| November 21, 2022 | P00002 | OTHER ADMINISTRATIVE ACTION | no money | IND-DIRECTED DEVELOPMENT OF ANTIVIRAL THERAPIES TO COMBAT DISEASES OF PANDEMIC POTENTIAL |
| September 12, 2022 | P00001 | OTHER ADMINISTRATIVE ACTION | +$3,377,004 | IND-DIRECTED DEVELOPMENT OF ANTIVIRAL THERAPIES TO COMBAT DISEASES OF PANDEMIC POTENTIAL |
| July 26, 2022 | base | not on file | +$15,336,338 | IND-DIRECTED DEVELOPMENT OF ANTIVIRAL THERAPIES TO COMBAT DISEASES OF PANDEMIC POTENTIAL |
Last refreshed November 4, 2026 at 2:31 PM UTC.